Boryung Corporation (KRX:003850)
South Korea · Delayed Price · Currency is KRW 9,250.00
-30.00 (-0.32%)
Jan 30, 2026, 3:30 PM KST
Boryung Revenue
Boryung had revenue of 280.01B KRW in the quarter ending September 30, 2025, with 3.31% growth. This brings the company's revenue in the last twelve months to 1.03T, up 3.79% year-over-year. In the year 2024, Boryung had annual revenue of 1.02T with 18.32% growth.
Revenue (ttm)
1.03T
Revenue Growth
+3.79%
P/S Ratio
0.76
Revenue / Employee
671.23M
Employees
1,533
Market Cap
781.44B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.02T | 157.48B | 18.32% |
| Dec 31, 2023 | 859.63B | 99.15B | 13.04% |
| Dec 31, 2022 | 760.48B | 133.20B | 21.23% |
| Dec 31, 2021 | 627.28B | 65.41B | 11.64% |
| Dec 31, 2020 | 561.87B | 37.60B | 7.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.06T |
| Chong Kun Dang Pharmaceutical | 1.68T |
| Dong-A Socio Holdings | 1.40T |
| DongKook Pharmaceutical | 894.93B |
| Huons Global | 825.44B |
| Dong-A ST | 770.63B |
| JW Pharmaceutical | 764.21B |
| Ildong Pharmaceutical | 575.66B |